VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • March 1st, 2023 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Ann McGuire (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of January 1, 2023 (the “Effective Date”).
VERACYTE, INC.Veracyte, Inc. • March 1st, 2023 • Services-medical laboratories • California
This letter confirms the agreement (“Agreement”) between you (“Executive” or “you”) and Veracyte, Inc. (the “Company”) concerning the terms of your transition and separation from employment and offers you certain benefits to which you would not otherwise be entitled, conditioned upon your provision of a general release of claims and covenant not to sue upon the Termination Date (defined below) as provided herein. If you agree to the terms outlined herein, please sign and return this Agreement to me in the timeframe outlined below.
